The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of KN046 plus paclitaxel/cisplatin as first-line treatment for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC).
 
Jianming Xu
No Relationships to Disclose
 
Rongrui Liu
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Qingxia Fan
No Relationships to Disclose
 
Shegan Gao
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Mingquan Cai
No Relationships to Disclose
 
Dong Yan
No Relationships to Disclose
 
Qianqian Liang
Employment - Alphamab
 
Qiong Wu
Employment - Alphamab
 
Baohong Guo
Employment - Alphamab
 
Yakun Qi
Employment - Alphamab
 
Ting Xu
Leadership - Alphamab